{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:23:31Z","timestamp":1787851411822,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016273","name":"Menarini Silicon Biosystems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005410","name":"American-Italian Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010463","name":"Institut Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.esmoop.2026.108331","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:21:57Z","timestamp":1785874917000},"page":"108331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-6550","authenticated-orcid":false,"given":"E.","family":"Nicol\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Foffano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4749-4410","authenticated-orcid":false,"given":"S.","family":"Cyrille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5434-203X","authenticated-orcid":false,"given":"W.","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Arpino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3251-4060","authenticated-orcid":false,"given":"F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Munoz-Arcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3363-8512","authenticated-orcid":false,"given":"L.","family":"Pontolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9496-6719","authenticated-orcid":false,"given":"C.","family":"Gianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8949-2296","authenticated-orcid":false,"given":"N.","family":"Bayou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0447-9967","authenticated-orcid":false,"given":"A.A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"Gradishar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8313-4834","authenticated-orcid":false,"given":"L.","family":"Gerratana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-439X","authenticated-orcid":false,"given":"X.K.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Renault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cristofanilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5932-8949","authenticated-orcid":false,"given":"F.-C.","family":"Bidard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0514-0152","authenticated-orcid":false,"given":"C.","family":"Reduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.esmoop.2026.108331_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108331_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.molcel.2015.10.031","article-title":"Breast tumor heterogeneity: source of fitness, hurdle for therapy","volume":"60","author":"Koren","year":"2015","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.esmoop.2026.108331_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108331_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41523-024-00706-7","article-title":"Circulating tumor cells in breast cancer: clinical validity and utility","volume":"10","author":"Thomas-Bonafos","year":"2024","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108331_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular vesicles in cancer: cell-to-cell mediators of metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell"},{"issue":"27","key":"10.1016\/j.esmoop.2026.108331_bib6","doi-asserted-by":"crossref","first-page":"19283","DOI":"10.18632\/oncotarget.25019","article-title":"Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients","volume":"9","author":"Nanou","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.esmoop.2026.108331_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41416-019-0726-9","article-title":"Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival","volume":"122","author":"Nanou","year":"2020","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108331_bib8","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3390\/biomedicines12102359","article-title":"Blood extracellular vesicles beyond circulating tumour cells: a valuable risk stratification biomarker in high-risk non-muscle-invasive bladder cancer patients","volume":"12","author":"Magri","year":"2024","journal-title":"Biomedicines"},{"issue":"18","key":"10.1016\/j.esmoop.2026.108331_bib9","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.3390\/cancers14184404","article-title":"Characterizing circulating tumor cells and tumor-derived extracellular vesicles in metastatic castration-naive and castration-resistant prostate cancer patients","volume":"14","author":"Isebia","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.esmoop.2026.108331_bib10","article-title":"Tumor-derived extracellular vesicles as complementary prognostic factors to circulating tumor cells in metastatic breast cancer","volume":"7","author":"Nanou","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108331_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamaoncol.2020.5660","article-title":"Efficacy of circulating tumor cell count-driven vs clinician-driven first-line therapy choice in hormone receptor-positive, ERBB2-negative metastatic breast cancer: the STIC CTC randomized clinical trial","volume":"7","author":"Bidard","year":"2021","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2026.108331_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1200\/JCO.23.00456","article-title":"Overall survival with circulating tumor cell count-driven choice of therapy in advanced breast cancer: a randomized trial","volume":"42","author":"Bidard","year":"2024","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.esmoop.2026.108331_bib13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"10.1016\/j.esmoop.2026.108331_bib14","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.esmoop.2026.108331_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186562","article-title":"Quantifying HER-2 expression on circulating tumor cells by ACCEPT","volume":"12","author":"Zeune","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108331_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.esmoop.2026.108331_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.critrevonc.2018.12.004","article-title":"The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): international expert consensus paper","volume":"134","author":"Cristofanilli","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108331_bib18","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.3390\/cells9071718","article-title":"The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast\u2014long-term prognostic significance","volume":"9","author":"Narbe","year":"2020","journal-title":"Cells"},{"issue":"24","key":"10.1016\/j.esmoop.2026.108331_bib19","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1158\/1078-0432.CCR-25-0807","article-title":"Prognostic significance and predictive value of circulating tumor cells in invasive lobular breast carcinoma\u2014an exploratory analysis of the STIC CTC trial","volume":"31","author":"Sandoval","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.esmoop.2026.108331_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105302","article-title":"Blood tumor load: combining biomarkers to increase the proportion of informative patients","volume":"10","author":"Dathathri","year":"2025","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.esmoop.2026.108331_bib21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41391-020-00304-1","article-title":"Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer","volume":"24","author":"Oeyen","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.esmoop.2026.108331_bib22","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1158\/1078-0432.CCR-25-0327","article-title":"Circulating tumor cells dynamics after CDK4\/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II study","volume":"31","author":"Gerratana","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108331_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41571-024-00963-2","article-title":"Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?","volume":"22","author":"Drago","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"issue":"suppl 17","key":"10.1016\/j.esmoop.2026.108331_bib24","volume":"43","author":"Tolaney","year":"2025","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.esmoop.2026.108331_bib25","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMoa2407086","article-title":"Trastuzumab deruxtecan after endocrine therapy in metastatic breast cancer","volume":"391","author":"Bardia","year":"2024","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.esmoop.2026.108331_bib26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13058-020-01323-5","article-title":"HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer","volume":"22","author":"Nanou","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.esmoop.2026.108331_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/tbcr-23-55","article-title":"Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer","volume":"5","author":"Nicol\u00f2","year":"2024","journal-title":"Transl Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.esmoop.2026.108331_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41416-022-02055-3","article-title":"Large tumour-derived extracellular vesicles as prognostic indicators of metastatic cancer patient survival","volume":"128","author":"Goberdhan","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.esmoop.2026.108331_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2019.06.012","article-title":"Tumor-derived extracellular vesicles in breast cancer: from bench to bedside","volume":"460","author":"Wang","year":"2019","journal-title":"Cancer Lett"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926022738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:34:40Z","timestamp":1787848480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926022738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2059702926022738"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108331","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.108331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"108331"}}